bioRxiv Science⌕ Search

Biology subjects

Parks, M. M.

Publications and source records attributed to Parks, M. M..

2 recordsLinked to original sources

Blind Virtual Screening at Scale: A Scalable End-to-End Pipeline for Blind Docking and Affinity Prediction

Accurate and scalable prediction of protein-ligand interactions remains a central challenge in computational drug discovery, especially when the binding site is unknown (i.e., blind docking). We present a high-throughput, end-to-end algorithm for virtual screening that combines DiffDock, a diffusion-based generative model for blind docking, with UniDock Vina, an algorithm for rapid scoring. We benchmarked this approach on the CASF-2016 and DUD-E datasets, analyzing pose quality, scoring accuracy, and screening performance. We find that competitive screening power can be achieved when generating and scoring as few as three poses and without pose refinement, which facilitates scalability. Notably, our method achieves 86.78% and 82.00% for the percent of actives among the top 1% and 10% of ranked ligands, respectively, when generating as few as three poses per protein-ligand pair. The workflow is scalable, supporting blind docking and affinity prediction at a mean throughput of 0.76 seconds per protein-ligand pair when generating 40 ligand poses in batched mode parallelized to 8 NVIDIA A100 80G GPUs. These results demonstrate that accurate, large-scale blind virtual screening is feasible and offers a practical solution for screening against novel or less characterized protein targets. Code is available at: https://github.com/xinyu-dev/blind-screening-benchmark

bioinformatics↗

A clinically validated human capillary blood transcriptome test for global systems biology studies

Chronic diseases are the leading cause of morbidity and mortality globally. Yet, the majority of them have unknown etiologies, and genetic contribution is weak. In addition, many of the chronic diseases go through the cycles of relapse and remission, during which the genomic DNA does not change. This strongly suggests that human gene expression is the main driver of chronic disease onset and relapses. To identify the etiology of chronic diseases and develop more effective preventative measures, a comprehensive gene expression analysis of the human body is needed. Blood tissue is easy to access and contains a large number of expressed genes involved in many fundamental aspects of our physiology. We report here the development of a whole blood transcriptome clinical test that is high throughput, automated, inexpensive, and clinically validated. The test requires only 50 microliters of blood from a finger prick, enabling access by diverse populations that have been traditionally under-represented in clinical research. The transcripts in the samples are preserved at the time of collection and can be stored and/or transported at ambient temperatures for up to 28 days. The sample preservative protects integrity, while also inactivating all pathogens (bacteria, fungi, and viruses), enabling safe transportation globally. Given its unique set of usability features and clinical performance, this test should be integrated into longitudinal, population-scale, systems biology studies.

systems biology↗